Gains May Be On The Menu For Apogee Therapeutics Inc (NASDAQ: APGE)
Currently, there are 45.02M common shares owned by the public and among those 36.31M shares have been available to trade. The company’s stock has a 5-day price change of -9.72% and -34.75% over the past three months. APGE shares are trading -18.19% year to date (YTD), with the 12-month market performance up to 17.28% higher. […]
